Trial Profile
Phase IV Study to Investigate if Valproate Add-on Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Valproic acid (Primary) ; Quetiapine
- Indications Bipolar disorders
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 02 Feb 2013 NCT reports actual initiation date as Jul 2005 and actual patient number as 17.
- 25 Jan 2013 Actual end date Jun 2006 added as reported by ClinicalTrials.gov.
- 01 Oct 2009 Results were published in Acta Psychiatrica Scandinavica.